Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Current Opinion in Molecular Therapeutics|March 16, 2001
Novel strategies for therapeutic design in molecular oncology using gene expression profilesM S Ricci, W S el-DeiryThe Journal of Biological Chemistry|August 4, 2001
Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approachT F Burns, W S El-DeiryCurrent Medicinal Chemistry|April 17, 2014
HIF-1 signaling in drug resistance to chemotherapyN A Warfel, W S El-DeiryClinical Chemistry|June 1, 1996
Biological and clinical importance of the p53 tumor suppressor geneV E Velculescu, W S El-DeiryClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2G S Wu, W S El-DeiryDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
Tumor suppressor gene therapy for cancer: from the bench to the clinicR D Meng, W S El-DeiryCell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 13, 1999
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cellsK O Mitchell, W S El-DeiryExperimental Cell Research|January 5, 2001
p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gammaR D Meng, W S El-DeiryOncogene|April 4, 1996
Regulation of p21WAF1/CIP1 expression by p53-independent pathwaysY X Zeng, W S el-DeiryPageof 9